Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Therapeutic area

Psychiatric disorders – page 9

  • 546 clinical trials
  • 252 recruiting
  • 147 conditions
  • 26 countries

Conditions in this area

147 conditions with trials, the busiest first

Dementia Alzheimer's type87Major depression57Schizophrenia39Depression35Narcolepsy19Cognitive disorder18Bipolar disorder16Autism spectrum disorder15Insomnia15Post-traumatic stress disorder14Psychotic disorder14Drug use disorder13Alcohol use disorder12Attention deficit hyperactivity disorder9Dementia9Obstructive sleep apnoea syndrome9Brain injury8Irritable bowel syndrome8Phenylketonuria8Bipolar I disorder7Drug dependence7Hypersomnia7Lennox-Gastaut syndrome7Anorexia nervosa6+123

Clinical trials in Psychiatric disorders

546 trials across Europe, recruiting first

Type of trial
Recruitment status
Quick filters

546 clinical trials

Dementia+7

Recruiting

Study on the Accuracy of Tau PET ([18F]RO6958948) and Vizamyl (Flutemetamol 18F) in Diagnosing Mild Cognitive Symptoms and Risk of Alzheimer's Disease

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Flutemetamol (18F)
  • Sponsor:Region Skane

Frontotemporal dementia

Recruiting

Study on the Safety and Effects of DNL593 for Patients with Frontotemporal Dementia

Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:DNL593
  • Sponsor:Denali Therapeutics Inc.

Dementia Alzheimer's type

Recruiting

Study on Brain Changes in Alzheimer's Disease Using Flutemetamol (18F) and Fludeoxyglucose (18F) in ALFA Project Participants

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Flutemetamol (18F)
  • Sponsor:Barcelonabeta Brain Research Center

Psychotic disorder+2

Recruiting

Study on the Effects of GT-002 and Oxazepam for Cognitive Impairment in Schizophrenia Patients

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · Healthy volunteers
  • Substances:GT-002
  • Sponsor:Region Hovedstadens Psykiatriske

Dementia Alzheimer's type

Recruiting

Study on Flutemetamol (18F) for Detecting Amyloid Pathology in Cognitively Normal Elderly at Risk for Alzheimer's Disease

Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:65+ years · Healthy volunteers
  • Substances:Flutemetamol (18F)
  • Sponsor:Amsterdam UMC Stichting

Schizophrenia

Recruiting

Study on Brain Inflammation in Schizophrenia Patients Using 18F-DPA-714

InvestigationalNo placebo
Countries:FranceFrance
  • Participants:18–64 years · Healthy volunteers
  • Substances:N,N-Diethyl-2-(2-(4-(2[(18)F]-Fluoroethoxy)Phenyl)5,7Dimethylpyrazolo[1,5A]Pyrimidin-3-Yl)Acetamide
  • Sponsor:Inserm

Attention deficit hyperactivity disorder

Recruiting

Study on the Effects of Methylphenidate on Brain Function in Adults with ADHD, with or without Mood Disorders, Compared to Placebo

Registered drug
Countries:FranceFrance
  • Participants:18–64 years · Healthy volunteers
  • Substances:Methylphenidate Hydrochloride
  • Sponsor:Les Hopitaux Universitaires De Strasbourg

Dementia Alzheimer's type

Recruiting

Study on How Florquinitau (18F) Affects Brain Circuits in Early Alzheimer's Disease Stages

InvestigationalNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Florquinitau (18F)
  • Sponsor:UZ Leuven

Dementia Alzheimer's type

Recruiting

Study of Flortaucipir (18F) PET Imaging in Healthy Elderly Twins to Investigate Early Signs of Alzheimer's Disease

InvestigationalNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:65+ years · Healthy volunteers
  • Substances:Flortaucipir (18F)
  • Sponsor:Amsterdam UMC Stichting

Drug use disorder

Recruiting

Study on the Effects of Naldemedine and Tramadol on Opioid-Induced Bowel Dysfunction in Patients Using Opioids

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · Healthy volunteers
  • Substances:NALDEMEDINE
  • Sponsor:Aalborg University Hospital

Autism spectrum disorder

Recruiting

Study on Improving Social Interaction in Children with Autism Using Oxytocin Nasal Spray and Therapy

Registered drug
Countries:BelgiumBelgium
  • Participants:0–17 years · Healthy volunteers
  • Substances:Oxytocin
  • Sponsor:UZ Leuven

Major depression

Recruiting

Study on the Effects of Escitalopram and Bupropion on Dopamine Levels in Patients with Major Depression

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Escitalopram Oxalate
  • Sponsor:Medical University Of Vienna

Substances studied in this area

The therapies tested most often in Psychiatric disorders trials.

Sodium Chloride25 clinical trialsTrospium Chloride17 clinical trialsXanomeline Tartrate16 clinical trialsCannabidiol15 clinical trialsDry Extract From Psilocybe Cubensis (15-25:1), Extraction Solvent: Methanol14 clinical trialsFlorquinitau (18F)14 clinical trialsOxytocin13 clinical trialsAripiprazole12 clinical trialsFlorbetaben (18F)12 clinical trials
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.